Background: Incidence rates of cervical and uterine cancer are usually determined without elimination of hysterectomized women from the population at risk. The aim of this report is to provide age-specific incidence rates of these cancers uncorrected and corrected for hysterectomized women in Germany and to compare these findings with the international literature. Methods: Most recent incidence estimates of cervical and uterine cancer (11,318 and 26,379 cervical and uterine cancer cases, respectively) of the years 2003-7 in Germany were included. The population at risk was corrected by age-specific prevalence estimates of hysterectomy in Germany. Thereafter, corrected incidence rates were estimated. Results: The incidence of cervical and uterine cancer among women aged 65 years or more increased by 67% (cervical cancer from 16.5 to 27.5 and uterine cancer from 79.6 to 133.2 per 100,000 person-years) after correction for hysterectomized women. The distortion of the age pattern of uncorrected incidence rates of cervical cancer for women aged 45-64 years (apparent decline) in Germany virtually disappeared after correction for hysterectomized women. Correction for hysterectomized women resulted in larger relative increases of the cancer rates in the U.S. than European countries. Conclusions: Inclusion of hysterectomized women in the population at risk results in a marked underestimate of the incidences of cervical and uterine cancer among elderly women and potentially biases age-specific incidence patterns and lifetime risk estimates of these cancers. Continuous monitoring of the incidences of cervical cancer corrected for hysterectomized women is needed.
Introduction
H ysterectomy is the most frequently performed major surgical procedure in gynaecology across many places in the world including Germany. [1] [2] [3] For example, in the year 2005 in the U.S. 4 and Germany, 2,3 overall 573,592 and 153,621 hysterectomies, respectively, were performed. Most often, hysterectomies are undertaken for benign diseases of the genital tract including leiomyoma, endometriosis and genital prolapse. 2, 4, 5 For example, 88%, 81% and 78% of hysterectomies in the U.S. , Germany (2005-6) and Sweden (1987 Sweden ( -2003 , respectively, were related to benign diseases of the genital tract. 2, 4, 5 Several studies have shown marked variations of hysterectomy rates among and within industrialized countries 4, [6] [7] [8] [9] [10] and over time. 5, 6, 10, 11 A recent comparison of hysterectomy rates for benign diseases of the genital tract in Sweden Incidence rates of cervical and uterine cancer are usually determined without elimination of hysterectomized women from the population at risk, thus resulting in an underestimate of the incidence of these tumours in the population. The aim of this report is to provide age-specific incidence rates of cervical and uterine cancer uncorrected and corrected for the prevalence of hysterectomy in Germany and to compare these findings with other countries that also published uncorrected and corrected age-specific incidence rates of cervical and uterine cancer.
Methods
Most recent incidence estimates of cervical and uterine cancer (cases and uncorrected person-years) of the years 2003-7 as provided by the German Society of Epidemiologic Cancer Registries (www. GEKID.de) were extracted. GEKID regularly provides updated incidence estimates based on pooling of high-quality populationbased cancer registries defined as registries with a high registration completeness of cancer. 12 These 10 registries included Bavaria, Brandenburg, Bremen, Hamburg, Mecklenburg-Vorpommern, Lower Saxony (northern part), Northrhine-Westphalia (administrative district of Münster), Saarland, Saxony and Schleswig-Holstein. In 2007, these registries covered a population of 37.9 million people (46% of the German population). From 2003 through 2007, overall 11,318 and 26,379 newly diagnosed women with cervical and uterine cancer respectively have been registered.
As previously described, 2 we used age-specific prevalences of hysterectomy (5-year age groups) in the general population from a population-based survey in Bremen, Germany, of 3,000 women aged 40-69 years in 2000. 13 Age-specific prevalence of hysterectomy revealed a S-shaped pattern in Bremen, as well as in a survey in Utah, USA.
14 Thus, one year age-specific probabilities of hysterectomy prevalence and extrapolated hysterectomy probabilities (outside the observed age range) were estimated using this pattern from a logistic regression model. The model indicated an upper limit of hysterectomy prevalence in the population of 40.7% (called main analysis). This value minimized the Pearson goodness-of-fit statistic from an iterative search across a range (30-60%) of upper limits of the hysterectomy prevalence for women in this oldest age group. In a sensitivity analysis, the same statistical approach was applied to the lower and upper 95% confidence interval limits of the age-specific prevalences of the survey in Bremen. The upper limits of hysterectomy prevalences to minimize the Pearson goodness-of-fit statistic were 35.5% and 45.7% respectively. The estimated and extrapolated age-specific prevalence estimates for the main and sensitivity analyses are presented in Supplementary table 1. Age-specific and age-standardized incidences of cervical and uterine cancer were then recalculated using the prevalence-corrected person-years at risk as based on the main analysis and the sensitivity analyses. The cumulative risk that a women with an intact uterus will develop cervical or uterine cancer during the age span 0-64 years and 65-84 years in the absence of other competing causes of death was estimated by summation of the age-specific rates over each year of age from birth to age 64 years and age 65 to 84 years, respectively, and by use of the formula cumulative risk = 1 À exp(Àcumulative rate). 15 For the international comparison, a literature search to identify publications that provided uncorrected and corrected age-specific incidence rates of cervical and uterine cancer was undertaken with the following search strategy: ('hysterectomy' [MeSH] or 'hysterectomy' [All Fields]) and ('uterine neoplasms'/epidemiology* or 'uterine cervical neoplasms'/epidemiology*) and 'humans' [MeSH] and 'female' [MeSH] and 'incidence' [MeSH] . This search was supplemented by review of reference lists of suitable publications. Data from tables or figures of retrieved publications were extracted and displayed as semilogarithmic plots of the uncorrected and corrected age-specific incidences. Statistical analyses were conducted with SAS version 9.2 (SAS Institute Inc, Cary, NC, USA).
Results
The overall estimated prevalence of hysterectomy in Germany across the entire age range was 16% (sensitivity analysis: 14-19%) and was positively associated with age. Among women aged 65 years or more, at least one-third of all women were hysterectomized. The percentage change of the cancer rates after correction for hysterectomized women depended on the hysterectomy prevalence and therefore on age. Corrected rates among women less than 65 years were only slightly higher than uncorrected rates (11%, sensitivity analysis: 9-13%). However, among women aged 65 years or more, rates increased by 67% (sensitivity analysis: 54-85%) (main analysis: cervical cancer: from 16.5 to 27.5 per 100,000 person-years; uterine cancer: from 79.6 to 133.2 per 100,000 person-years) (table 1) .
Similarly, whereas the cumulative risk to develop cervical or uterine cancer of women with intact uteri during the age span 0-64 years increased by 22% (sensitivity analysis: 17-27%) for cervical cancer (main analysis: from 5.9 to 7.2 per 1000 women) and by 44% (sensitivity analysis: 36-54%) for uterine cancer (main analysis: from 7.8 to 11.2 per 1000 women), the cumulative risk to develop these cancers during the age span 65-84 years increased by 67% (sensitivity analysis: 55-82%) (main analysis: cervical cancer: from 3.3 to 5.5 per 1000 women; uterine cancer: from 16.2 to 25.0 per 1000 women) after correction for hysterectomized women (table 1) .
Among women aged 45-64 years, the uncorrected age-specific incidence of cervical cancer decreased from 18.9 (45-49 years) to 13.6 per 100,000 person-years (60-64 years). This drop of the age-specific rate virtually disappeared after elimination of hysterectomized women from the population at risk (figure 1).
The uncorrected crude incidence rates of cervical and uterine cancer in Germany (entire age range) were 11.7 and 27.3 per 100,000 person-years, respectively. After correction for hysterectomized women, these rates increased to 14.0 and 32.5 per 100,000 person-years, reflecting a 20% increase of the crude rates. Due to the different weightings of age-specific incidence rates when rates are age-standardized, the relative change of the age-standardized incidences after correction of the person-time at risk depended on the choice of external age standard distribution. For rates standardized according to the European standard population, cervical and uterine cancer incidences increased by 21% and 46%, respectively. For rates standardized according to the World standard population, these rates increased by 17% and 53%, respectively (table 1) .
The relative change of the incidence of cervical and uterine cancer after correction for hysterectomized women tended to be larger in the U.S. than in European countries for both cervical and uterine cancer (table 2). The international comparison of uncorrected and corrected age-specific incidence rates of cervical cancer revealed that the distortion potential of the age-specific patterns depends on the country. Finland (1991-9) and England and Wales (1992) showed very similar age-patterns of the uncorrected and corrected rates whereas Upstate New York (1977-9) and Germany (2005-6) showed different age patterns of the uncorrected and corrected rates (supplementary figure 1) .
The uncorrected age-specific incidence patterns of uterine cancer in Denmark (1978) showed a plateau at ages 60-79 years. However, the corrected age-specific incidence pattern showed a continuous increase at these ages. The comparison of the uncorrected and corrected incidence age patterns of uterine cancer in Upstate New York (1977-9), Finland (1991-9), Surveillance, Epidemiology and ; incidence rates expressed as cases per 100,000 person-years. Uterine Cancer Cervical Cancer
Gray graphs present incidence rates based on the sensitivity analysis Figure 1 Age-specific incidence rates of cervical and uterine cancer in Germany 2003-7 with and without correction for hysterectomy prevalence. Graphs with filled dot symbols indicate uncorrected rates, graphs with circles indicate corrected rates End Results (SEER) (1992-2000) and Germany (2005-6) showed similar age patterns despite the increases of the corrected rates as compared with the uncorrected rates (supplementary figure 2).
Discussion
As the estimated prevalence of hysterectomy among women aged 65 years or more was 40.2% in Germany, elimination of hysterectomized women from the population at risk resulted in increases of the incidence of cervical and uterine cancer most pronounced among elderly women. Among women aged 65 years or more, incidence rates of cervical and uterine cancer increased by 67%. Our findings are in line with previous studies that corrected cervical and uterine cancer incidences for hysterectomy rates in the U.S. 14, [18] [19] [20] For example, Merrill 19 observed a 73% and 38% increase of the incidence of uterine and cervical cancer among white women, respectively, after correction for hysterectomy in the U.S. 1998 through 2002. The generally higher hysterectomy prevalence in the United States compared with European countries resulted in greater relative changes of the incidences of cervical and uterine cancer after correction for hysterectomized women.
The lack of exclusion of hysterectomized women from the population at risk is problematic for several reasons. First, the age-specific incidence of cervical cancer is not only underestimated but the overall age pattern may even be distorted (e.g. a considerable decrease of the uncorrected age-specific incidence from ages 40-44 to 60-64 years in Germany virtually disappeared after correction). The American College of Obstetrics and Gynaecology (ACOG) 24 recommendations on cervical cancer stated that in white women the 'rate of new-onset cervical cancer peaks in the middle of the fifth decade of life and then decreases' and refers to uncorrected age-specific incidence rates of cervical cancers in the U.S. 24 Although corrected age-specific incidence rates of cervical cancer in the U.S. have not been published until now, the overall analysis of the uncorrected and corrected age-adjusted incidence of cervical cancer in the U.S. and the high hysterectomy rates in the U.S. 4 suggest that the uncorrected age-specific incidence rates of cervical cancer at ages 65 years and more are substantially underestimating the true risk of cervical cancer among women with intact uteri. The overall incidence age pattern of uterine cancer, that is, a steady increase of the age-specific incidence rate up to ages 80-84 years, was not distorted in Germany and the U.S. 18 However, in Denmark the uncorrected age-specific incidence rates of uterine cancer falsely revealed a plateau at ages 60-79 years that virtually disappeared after correction. 25 Second, the lack of correction for hysterectomy prevalence potentially biases incidence time trends of cervical and uterine cancers, 21 ethnic comparisons of cervical and uterine cancer incidences, 18, 19 lifetime risk estimates, cost-effectiveness analyses, economic evaluations and health technology assessments of screening programs related to these cancers.
There are several factors that limit the results. First, population-based survey data from the Federal State of Bremen may not necessarily be representative for Germany. However, preliminary data from a recent survey in the Federal State of Rhineland-Palatinate (2005-8) provided very similar prevalence estimates. 26 Also, a recent population-based study in Dortmund, Northrhine-Westphalia (2003-4), 27 revealed even higher prevalences than in Bremen. Although the sensitivity analyses (that accounted for the random error of the age-specific hysterectomy prevalence estimates of the survey in Bremen) revealed some uncertainty of the estimates of the hysterectomy-corrected incidence rates, this uncertainty was not substantial. Second, based on the survey data, a distinction between total and subtotal hysterectomies was not possible. However, women undergoing partial hysterectomy are still at risk for cervical cancer. For example, analyses of hysterectomies in Germany in 2005 and 2006 revealed that about 4.1% of all hysterectomies were performed as subtotal hysterectomies, 2 which is very similar to the U.S. in 1998-2002 (3% among white women). 19 In conclusion, incidence rates of cervical and uterine cancer that are uncorrected for hysterectomized women considerably underestimate the rates of these cancers in elderly women with intact uteri. The provided uncorrected and corrected incidence rates underscore the need to more accurately describe the impact of these cancers on women truly at risk. Continuous monitoring of the incidences of cervical and uterine cancer corrected for hysterectomized women is needed.
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Key points
Incidence rates of cervical and uterine cancer that are uncorrected for hysterectomized women considerably underestimate the rates of these cancers in elderly women with intact uteri. Without correction for hysterectomized women, the age-specific incidence of cervical cancer is not only underestimated but the overall age pattern in Germany and some other countries is distorted and therefore misleading. Continuous monitoring of the incidences of cervical and uterine cancer corrected for hysterectomized women is needed.
